Can we define the mechanism of antitumor response observed during clinical adoptive immunotherapy? [1]

Journal of the National Cancer Institute

Volumn 89, Issue 18, 1997, Pages 1380-

  Merrouche, Y ^a   Negrier, S ^a   Puisieux, I ^a   Favrot, M ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR CELL VACCINE;

ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; DELAYED HYPERSENSITIVITY; HUMAN; INTRADERMAL DRUG ADMINISTRATION; KIDNEY CARCINOMA; LETTER; MELANOMA; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY;

EID: 0030858196     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.18.1380     Document Type: Letter

References (8)